ATE415814T1 - Melusin, ein muskelspezifisches protein, als zielmolekül für wirkstoffe zur vorbeugung und behandlung von herzinsuffizienz, und verwendungen davon - Google Patents

Melusin, ein muskelspezifisches protein, als zielmolekül für wirkstoffe zur vorbeugung und behandlung von herzinsuffizienz, und verwendungen davon

Info

Publication number
ATE415814T1
ATE415814T1 AT02808278T AT02808278T ATE415814T1 AT E415814 T1 ATE415814 T1 AT E415814T1 AT 02808278 T AT02808278 T AT 02808278T AT 02808278 T AT02808278 T AT 02808278T AT E415814 T1 ATE415814 T1 AT E415814T1
Authority
AT
Austria
Prior art keywords
melusin
heart failure
actives
muscle
prevention
Prior art date
Application number
AT02808278T
Other languages
English (en)
Inventor
Mara Brancaccio
Lorenzo Silengo
Fiorella Altruda
Giuseppe Lembo
Luigi Fratta
Guido Tarone
Original Assignee
Univ Degli Studi Torino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Torino filed Critical Univ Degli Studi Torino
Application granted granted Critical
Publication of ATE415814T1 publication Critical patent/ATE415814T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0375—Animal model for cardiovascular diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02808278T 2002-12-19 2002-12-19 Melusin, ein muskelspezifisches protein, als zielmolekül für wirkstoffe zur vorbeugung und behandlung von herzinsuffizienz, und verwendungen davon ATE415814T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2002/000807 WO2004056176A1 (en) 2002-12-19 2002-12-19 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure

Publications (1)

Publication Number Publication Date
ATE415814T1 true ATE415814T1 (de) 2008-12-15

Family

ID=32676766

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02808278T ATE415814T1 (de) 2002-12-19 2002-12-19 Melusin, ein muskelspezifisches protein, als zielmolekül für wirkstoffe zur vorbeugung und behandlung von herzinsuffizienz, und verwendungen davon

Country Status (10)

Country Link
US (1) US7531714B2 (de)
EP (1) EP1575354B1 (de)
AT (1) ATE415814T1 (de)
AU (1) AU2002368482A1 (de)
CA (1) CA2505374A1 (de)
DE (1) DE60230196D1 (de)
DK (1) DK1575354T3 (de)
ES (1) ES2316655T3 (de)
IL (1) IL168859A (de)
WO (1) WO2004056176A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1404941B1 (it) * 2010-05-12 2013-12-09 Target Heart Biotec S R L Proteina di fusione di melusina ricombinante quale agente farmacologico nel trattamento di patologie cardiache e relative composizioni

Also Published As

Publication number Publication date
EP1575354A1 (de) 2005-09-21
ES2316655T3 (es) 2009-04-16
IL168859A (en) 2011-10-31
US7531714B2 (en) 2009-05-12
DK1575354T3 (da) 2009-01-26
US20060059577A1 (en) 2006-03-16
DE60230196D1 (de) 2009-01-15
WO2004056176A1 (en) 2004-07-08
CA2505374A1 (en) 2004-07-08
AU2002368482A1 (en) 2004-07-14
EP1575354B1 (de) 2008-12-03

Similar Documents

Publication Publication Date Title
DE602005007746D1 (de) Nukleinsäuren zur behandlung von erkrankungen im zusammenhang mit hmgb1
DE60005953D1 (de) Stapelbare statische mischelemente
EA200870019A1 (ru) Лактамовые соединения и способы их применения
DE602007006815D1 (de) 4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl-pyridin-3-ylamino)-pyrimidin-4-yloxyü-piperidin-1-carbonsäure isopropyl ester als stoffwechselmodulatore und behandlung von damit assoziierten erkrankungen
GT200600316A (es) Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida.
EA200700382A1 (ru) Фунгицидные композиции
EA200970131A1 (ru) Миметические антитела для glp-1 человека, композиции, способы и применения
DE602006017071D1 (de) Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EA201070187A1 (ru) Модифицированные ферменты лецитин-холестерин ацилтрансферазы
DE602004023721D1 (de) Zusammensetzungen und methoden für die behandlung von herzerkrankungen
DE602005013650D1 (de) Proteinhydrolysat zur behandlung von müdigkeit
ATE521631T1 (de) Verwendung von aimp2dx2 zur diagnose und behandlung von krebs
DE60122673D1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
BR0309122A (pt) Plantas com morfogênese melhorada e método para sua construção
ATE482706T1 (de) Behandlung bakterieller erkrankungen der atmungsorgane durch lokale applikation von fluorchinolonen
ATE415814T1 (de) Melusin, ein muskelspezifisches protein, als zielmolekül für wirkstoffe zur vorbeugung und behandlung von herzinsuffizienz, und verwendungen davon
DE60111620D1 (de) Aktiviertes protein c zur behandlung von pankreatitis
EA201070496A1 (ru) УГЛЕРОД-СВЯЗАННЫЕ МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ
DE502005007641D1 (de) Steigerung des proteinanteils tierischer organismen
ATE478707T1 (de) Kim-1-antikörper zur behandlung von th2- vermittelten erkrankungen
DE60121324D1 (de) Tiermodel für neurodegenerative erkrankungen
EA201070498A1 (ru) МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ С АМИДНЫМИ СВЯЗЯМИ
NO20075272L (no) Humane GLP-1 "mimetibodies", sammensetninger, fremgangsmater og anvendelser

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1575354

Country of ref document: EP